A carregar...
Trends and Predictors of Chemotherapy Use among Thyroid Cancer Patients in the National Cancer Database (2004–2013)
BACKGROUND/AIM: Beginning in 2011, the Food and Drug Administration (FDA) approved the use of multikinase inhibitors (MKIs) for medullary thyroid cancers (MTCs), and in 2013 MKIs were approved for metastatic differentiated thyroid cancers (DTCs). However, little is known about the use of chemotherap...
Na minha lista:
| Publicado no: | Eur Thyroid J |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
S. Karger AG
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5216190/ https://ncbi.nlm.nih.gov/pubmed/28101492 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000449379 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|